{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T13:28:38Z","timestamp":1747661318236,"version":"3.40.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","award":["2010\/08968-6","2010\/13859-1"],"award-info":[{"award-number":["2010\/08968-6","2010\/13859-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.schres.2014.05.015","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T10:12:51Z","timestamp":1401703971000},"page":"163-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR)"],"prefix":"10.1016","volume":"157","author":[{"given":"Marcos Leite","family":"Santoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Kiyomi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta Sessa","family":"Stilhano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia Nat\u00e1lia","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Maur\u00edcio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Cepollaro","family":"Diana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ary","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Affonseca","family":"Bressan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"Melaragno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Won","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Costhek","family":"Ab\u00edlio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sintia Iole","family":"Belangero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.schres.2014.05.015_bb0005","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/ng.171","article-title":"Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database","volume":"40","author":"Allen","year":"2008","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.schres.2014.05.015_bb0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10673229609017200","article-title":"Brain dopamine receptors: a primer on their current status, basic and clinical","volume":"3","author":"Baldessarini","year":"1996","journal-title":"Harv. Rev. Psychiatry"},{"issue":"21","key":"10.1016\/j.schres.2014.05.015_bb0015","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1093\/bioinformatics\/bti652","article-title":"BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing","volume":"21","author":"Bock","year":"2005","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopsych.2005.03.016","article-title":"Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo","volume":"58","author":"Bressan","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2014.05.015_bb0030","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/schbul\/sbn006","article-title":"Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?","volume":"35","author":"Calzavara","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2011.06.026","article-title":"Effects of antipsychotics and amphetamine on social behaviors in spontaneously hypertensive rats","volume":"225","author":"Calzavara","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.schres.2014.05.015_bb0035","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.pnpbp.2011.06.005","article-title":"The contextual fear conditioning deficit presented by spontaneously hypertensive rats (SHR) is not improved by mood stabilizers","volume":"35","author":"Calzavara","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archpsyc.55.1.67","article-title":"The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study","volume":"55","author":"Cannon","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2014.05.015_bb0045","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1073\/pnas.88.7.2673","article-title":"Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina","volume":"88","author":"Cutting","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"36","key":"10.1016\/j.schres.2014.05.015_bb0050","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1073\/pnas.0805493105","article-title":"Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation","volume":"105","author":"Dong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0055","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-4159.2006.04239.x","article-title":"Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damage","volume":"100","author":"Elliott-Hunt","year":"2007","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0278-5846(85)90181-2","article-title":"Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals","volume":"9","author":"Gerner","year":"1985","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1471-4159.2010.06585.x","article-title":"Antipsychotic-induced gene regulation in multiple brain regions","volume":"113","author":"Girgenti","year":"2010","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","article-title":"Lymphocytes as a neural probe: potential for studying psychiatric disorders","volume":"28","author":"Gladkevich","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0080","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/j.1460-2075.1990.tb08172.x","article-title":"Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes","volume":"9","author":"Grenningloh","year":"1990","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/138161211795049598","article-title":"Glycine transporter-1: a new potential therapeutic target for schizophrenia","volume":"17","author":"Hashimoto","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1017\/S1461145700001978","article-title":"N-Methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade","volume":"3","author":"Heresco-Levy","year":"2000","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"21","key":"10.1016\/j.schres.2014.05.015_bb0095","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.210221897","article-title":"Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity","volume":"97","author":"Holmes","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0100","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2014the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0006-8993(87)90447-1","article-title":"Chronic bombesin treatment increased the [3H]spiperone binding, glutamate decarboxylase and choline acetyltransferase activity in the rat brain","volume":"417","author":"Hsu","year":"1987","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1073\/pnas.98.2.625","article-title":"A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes","volume":"98","author":"Ilani","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.schres.2014.05.015_bb0115","first-page":"468","article-title":"Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification","volume":"12","author":"Javitt","year":"2009","journal-title":"Curr. Opin. Drug. Discov. Devel."},{"issue":"6","key":"10.1016\/j.schres.2014.05.015_bb0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2014.05.015_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2350-2-3","article-title":"Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients","volume":"2","author":"Kwak","year":"2001","journal-title":"BMC Med. Genet."},{"issue":"4","key":"10.1016\/j.schres.2014.05.015_bb0130","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/026988119901300405","article-title":"Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies","volume":"13","author":"Laruelle","year":"1999","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.schres.2014.05.015_bb0135","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.pnpbp.2011.06.003","article-title":"Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine","volume":"35","author":"Levin","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2014.05.015_bb0140","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","article-title":"MethPrimer: designing primers for methylation PCRs","volume":"18","author":"Li","year":"2002","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/WNF.0b013e318215c2f7","article-title":"Neurobiological background for the development of new drugs in schizophrenia","volume":"34","author":"Lopez-Munoz","year":"2011","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuropharm.2008.07.034","article-title":"Native glycine receptor subtypes and their physiological roles","volume":"56","author":"Lynch","year":"2009","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(96)12834-2","article-title":"Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain","volume":"213","author":"McCoy","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2006.07.015","article-title":"C57BL\/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA\/2J mice","volume":"143","author":"McNamara","year":"2006","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.schres.2014.05.015_bb0165","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1096\/fj.11-202069","article-title":"Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset","volume":"26","author":"Melas","year":"2012","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.schres.2014.05.015_bb0170","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.peptides.2004.01.003","article-title":"The bombesin\/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice","volume":"25","author":"Meller","year":"2004","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0175","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbrc.2004.04.081","article-title":"Functions of pancreatic beta cells and adipocytes in bombesin receptor subtype-3-deficient mice","volume":"318","author":"Nakamichi","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6656","key":"10.1016\/j.schres.2014.05.015_bb0180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/36568","article-title":"Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity","volume":"390","author":"Ohki-Hamazaki","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0893-133X(98)00053-0","article-title":"Decreased bombesin peptide response to cigarette smoking in schizophrenia","volume":"20","author":"Olincy","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2014.05.015_bb0190","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuropharm.2006.06.005","article-title":"Parallel regulation by olanzapine of the patterns of expression of 5-HT2A and D3 receptors in rat central nervous system and blood cells","volume":"51","author":"Padin","year":"2006","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0166-4328(97)00180-0","article-title":"A quantitative cytochrome oxidase mapping study, cross-regional and neurobehavioural correlations in the anterior forebrain of an animal model of Attention Deficit Hyperactivity Disorder","volume":"94","author":"Papa","year":"1998","journal-title":"Behav. Brain Res."},{"year":"1998","series-title":"The Rat Brain Stereotaxic Coordinates","author":"Paxinos","key":"10.1016\/j.schres.2014.05.015_bb0060"},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopsych.2010.03.029","article-title":"Epigenetic studies of psychosis: current findings, methodological approaches, and implications for postmortem research","volume":"69","author":"Pidsley","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-003-1683-8","article-title":"Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders","volume":"174","author":"Roth","year":"2004","journal-title":"Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.schres.2014.05.015_bb0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-4328(01)00425-9","article-title":"Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder\u2014the spontaneously hypertensive rat","volume":"130","author":"Russell","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.schres.2014.05.015_bb0215","doi-asserted-by":"crossref","first-page":"7136","DOI":"10.1073\/pnas.102163499","article-title":"Anticonvulsant activity of a nonpeptide galanin receptor agonist","volume":"99","author":"Saar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0149-7634(99)00058-5","article-title":"Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit\/hyperactivity disorder (AD\/HD)","volume":"24","author":"Sagvolden","year":"2000","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0225","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(93)91535-Z","article-title":"Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography","volume":"631","author":"Schotte","year":"1993","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine receptors and the dopamine hypothesis of schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.nbd.2011.03.001","article-title":"The first decade and beyond of transcriptional profiling in schizophrenia","volume":"45","author":"Sequeira","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.schres.2014.05.015_bb0245","doi-asserted-by":"crossref","first-page":"e895","DOI":"10.1371\/journal.pone.0000895","article-title":"DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons","volume":"2","author":"Siegmund","year":"2007","journal-title":"PLoS One"},{"issue":"2A","key":"10.1016\/j.schres.2014.05.015_bb0250","first-page":"224","article-title":"Localization and function of the D3 dopamine receptor","volume":"42","author":"Sokoloff","year":"1992","journal-title":"Arzneimittelforschung"},{"issue":"1\u20133","key":"10.1016\/j.schres.2014.05.015_bb0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.schres.2008.12.017","article-title":"Association of the 5\u2032-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia","volume":"109","author":"Stephens","year":"2009","journal-title":"Schizophr. Res."},{"issue":"48","key":"10.1016\/j.schres.2014.05.015_bb0260","doi-asserted-by":"crossref","first-page":"17489","DOI":"10.1073\/pnas.0508970102","article-title":"Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299","volume":"102","author":"Swanson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20133","key":"10.1016\/j.schres.2014.05.015_bb0265","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.schres.2009.12.024","article-title":"Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures","volume":"119","author":"Takahashi","year":"2010","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2014.05.015_bb0270","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0022-3565(24)29589-6","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment","volume":"297","author":"Tarazi","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.schres.2014.05.015_bb0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.tpj.6500418","article-title":"No evidence for binding of clozapine, olanzapine and\/or haloperidol to selected receptors involved in body weight regulation","volume":"7","author":"Theisen","year":"2007","journal-title":"Pharmacogenomics J."},{"issue":"3","key":"10.1016\/j.schres.2014.05.015_bb0280","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.57.3.237","article-title":"Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia","volume":"57","author":"Volk","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2014.05.015_bb0285","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.schres.2010.09.002","article-title":"A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder","volume":"124","author":"Wang","year":"2010","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0290","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MED.0b013e32831cf5aa","article-title":"Regulation and signaling of human bombesin receptors and their biological effects","volume":"16","author":"Weber","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"4","key":"10.1016\/j.schres.2014.05.015_bb0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0031-9384(99)00214-0","article-title":"Differential effects of social isolation upon body weight, food consumption, and responsiveness to novel and social environment in bombesin receptor subtype-3 (BRS-3) deficient mice","volume":"68","author":"Yamada","year":"2000","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.schres.2014.05.015_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0922-4106(93)90162-3","article-title":"Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus","volume":"245","author":"Zini","year":"1993","journal-title":"Eur. J. Pharmacol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641400245X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099641400245X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T05:52:44Z","timestamp":1746251564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099641400245X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":60,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S092099641400245X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2014.05.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"type":"print","value":"0920-9964"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of antipsychotic drugs on gene expression in the prefrontal cortex and nucleus accumbens in the spontaneously hypertensive rat (SHR)","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2014.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}